BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18176971)

  • 1. Expression of phosphatase and tensin homolog deleted on chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction.
    Yin LR; Chen ZX; Zhang SJ; Sun BG; Liu YD; Huang HZ
    World J Gastroenterol; 2008 Jan; 14(1):108-13. PubMed ID: 18176971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of antitumous effect of the complex prescription of Chinese crude drug in athymic mice with HCC].
    Sun BG; Chen ZX; Zhang SJ; Liu YD; Huang HZ; Yin LR
    Zhong Yao Cai; 2007 Nov; 30(11):1417-21. PubMed ID: 18323213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Jianpi Jiedu decoction to PTEN/ERK1 of athymic mice with hepatocellular carcinoma].
    Sun B; Zhou H; Deng Y; Huang H; Chen Z; Zhang S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(9):1144-8. PubMed ID: 19685755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of PTEN in athymic mice with HCC treated by complex prescription of Chinese crude drug].
    Sun BG; Chen ZX; Zhang SJ; Liu YD; Huang HZ; Yin LR
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1057-60. PubMed ID: 17672343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jianpijiedu fang improves survival of hepatocarcinoma mice by affecting phosphatase and tensin homolog, phosphoinositide 3-kinase, and focal adhesion kinase.
    Sun B; Meng J; Xiang T; Chen Z; Li Y; Lu L; Zhang S; Chen X
    J Tradit Chin Med; 2013 Aug; 33(4):479-85. PubMed ID: 24187869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous intratumoral injection of traditional Chinese herbal compound medicine Star-99 in treatment of hepatocellular carcinoma of mice.
    Lin LW; Sun Y; He YM; Gao SD; Xue ES; Lin XD; Yu LY; Lin XF; Yang YH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):49-54. PubMed ID: 14969837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
    Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
    Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
    Xi S; Peng Y; Minuk GY; Shi M; Fu B; Yang J; Li Q; Gong Y; Yue L; Li L; Guo J; Peng Y; Wang Y
    J Ethnopharmacol; 2016 Aug; 190():1-12. PubMed ID: 27235019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice.
    Lin LW; Lin XD; He YM; Gao SD; Xue ES
    World J Gastroenterol; 2003 Apr; 9(4):701-5. PubMed ID: 12679914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.
    Wang N; Feng Y; Tan HY; Cheung F; Hong M; Lao L; Nagamatsu T
    J Ethnopharmacol; 2015 Apr; 164():309-18. PubMed ID: 25700642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of QHF-cisplatin against hepatocellular carcinoma in a mouse model.
    Chen T; Yuan SJ; Wang J; Hu W
    World J Gastroenterol; 2015 Sep; 21(35):10126-36. PubMed ID: 26401077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.
    Chen WT; Zhu G; Pfaffenbach K; Kanel G; Stiles B; Lee AS
    Oncogene; 2014 Oct; 33(42):4997-5005. PubMed ID: 24141775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methylation detection of phosphatase and tensin homolog deleted on chromosome ten gene promoter in hepatocellular carcinoma samples by next-generation sequencing].
    Jing XK; Jiang QY; Li CS; Zhang NR; Chai YT; Feng F; Li BA; Li YK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Oct; 55(10):1220-1227. PubMed ID: 34706508
    [No Abstract]   [Full Text] [Related]  

  • 14. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
    Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
    Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft.
    Yu X; Lin XJ; Wang S; Liu X; Li W; Kou BX; Chai M; Chen D; Liu X; Wang X
    Integr Cancer Ther; 2018 Dec; 17(4):1216-1224. PubMed ID: 29978739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of overexpression of PTEN on apoptosis of liver cancer cells.
    Li MF; Guan H; Zhang DD
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
    Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma.
    Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S
    Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.